Orlistat-induced fulminant hepatic failure. - Wikidata - wikimedia - TriplyDB

Orlistat-induced fulminant hepatic failure.

Orlistat-induced fulminant hepatic failure.

http://www.wikidata.org/entity/Q42151566

about

Orlistat-induced fulminant hepatic failure.

http://www.wikidata.org/entity/Q42151566

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Orlistat-induced fulminant hepatic failure.

@en

Orlistat-induced fulminant hepatic failure.

@nl

type

label

Orlistat-induced fulminant hepatic failure.

@en

Orlistat-induced fulminant hepatic failure.

@nl

prefLabel

Orlistat-induced fulminant hepatic failure.

@en

Orlistat-induced fulminant hepatic failure.

@nl

P1433

Q42151566-A7BCF59C-612D-4998-B559-3CADBC192C42

P1476

Q42151566-093C0569-D082-4594-A992-F0CE82ECD67D

P2093

Q42151566-09AADFF9-4EE9-4B33-A68B-E8962D381EB8

Q42151566-15121AE8-706B-425C-BEF1-03674A74A36F

Q42151566-1BD6D5EB-A14D-4B65-8E07-95A3934C5BA6

Q42151566-203B5282-C6FB-454E-8A9A-9E6F3A3BDE5B

Q42151566-43D3571B-A921-40FB-A2FD-8880DCD4E7E7

Q42151566-8A4FA566-8078-4954-9890-EEC4EE67304B

P2860

Q42151566-01C4C3B5-F945-4B8A-8238-287AF5C5AA8E

Q42151566-0BC58316-F542-40BC-89E2-AEC90AAA30FE

Q42151566-0C5A5DD2-614C-4F10-9BBD-D7E90532DE70

Q42151566-14BF4E77-31AD-4D46-A5F7-2420C56153D6

Q42151566-1661D1A2-D343-4284-A573-F5040A341A21

Q42151566-17FBC07F-A748-47F2-AF8B-55065BE15CD2

Q42151566-33B102E0-9FFD-4B9A-9163-312176BEBCDD

Q42151566-7A2AE312-BE63-4D02-ACA9-E96910692F21

Q42151566-90C49D7D-EDD8-4365-8B34-86D96406C54E

Q42151566-9F32622E-B690-4857-BCDD-2A0C97DD2511

P304

Q42151566-6F6A9527-9823-4663-88A8-97BA8E55F074

P31

Q42151566-1CC9D812-A699-4D3C-80D6-ABA3991D4E24

P356

Q42151566-D213E7FB-9FA0-4145-8DDA-C38CA6C5ABC3

P433

Q42151566-5F4218F1-5B9C-497D-B132-2B26F1128082

P478

Q42151566-C6C141B2-DC38-4F16-8DA1-DE3F4DE6227C

P577

Q42151566-630BE15C-C5DE-4581-8A24-E5946B60E947

P698

Q42151566-EB9C4B2E-DD89-4901-8149-89D2E0D03C4A

P356

P1433

Clinical obesity

P1476

Orlistat-induced fulminant hepatic failure.

@en

P2093

C Droege

http://www.w3.org/2001/XMLSchema#string

D Sall

http://www.w3.org/2001/XMLSchema#string

D Schauer

http://www.w3.org/2001/XMLSchema#string

J Wang

http://www.w3.org/2001/XMLSchema#string

M Rashkin

http://www.w3.org/2001/XMLSchema#string

M Welch

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term pharmacotherapy for obesity and overweight

Anti-Obesity Drugs: A Review about Their Effects and Safety

Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink

Physicians' attitudes about obesity and their associations with competency and specialty: a cross-sectional study.

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

An integrated analysis of liver safety data from orlistat clinical trials.

Orlistat-associated adverse effects and drug interactions: a critical review.

Clinical and economic considerations of antiobesity treatment: a review of orlistat

Advances in the treatment of nonalcoholic fatty liver disease.

Orlistat associated subacute hepatic failure.

P304

342-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/COB.12075

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25826164

http://www.w3.org/2001/XMLSchema#string